10 likes | 19 Views
tGSK2982772, with potential effect to treat inflammatory diseases, potently binds to RIP1 with exquisite kinase specificity. In phase 2a clinical studies for psoriasis, rheumatoid arthritis, and ulcerative colitis.
E N D
GSK2982772 - CAS 1622848-92-3 Website: https://www.bocsci.com/gsk2982772-cas-1622848-92-3-item-7719.html Address: 45-16 Ramsey Road, Shirley, NY 11967, USA